We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Amphastar Antitrust Claims Nixed In Lovenox Suit

Law360 (February 19, 2009, 12:00 AM EST) -- In a setback for Amphastar Pharmaceuticals Inc., a federal judge has dismissed its cross-claims that two Sanofi-Aventis subsidiaries engaged in anti-competitive conduct and unfair competition by obtaining and enforcing through fraud patents related to Aventis’ anti-clotting drug Lovenox.

Judge Mariana R. Pfaelzer of the U.S. District Court for the Central District of California on Tuesday granted Aventis Pharma SA and Aventis Pharmaceuticals Inc.’s dismissal bid after finding the allegations that were able to survive Noerr-Pennington immunity failed to allege the necessary element of antitrust injury. They...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.